Results indicated that TRIM9 overexpression tumor cells treated with or without CQ exhibited decreased ZEB1 protein levels, whereas MG132-treated tumor cells demonstrated no such effects (Figure 4(d)). The gene discussed is ZEB1; the disease is neoplasm.